Drugs in the Pipeline
The vaccine candidate consists of the S, pre-S1, and pre-S2 surface antigens of the hepatitis B virus.
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
More than one-third of adult HIV patients receiving medical care have not been vaccinated
A vaccine for hepatitis E provides protection from the virus for at least 4.5 years, according to new research.
The Work Group who authored the new recommendations was made up of professionals from academic medicine, federal and state public health agencies, and medical societies.
MPR Weekly Dose Podcast
A second booster dose for some COVID-19 vaccines is authorized; Sotrovimab has its use limited due to the BA.2 Omicron subvariant; An investigational oral antiviral gains Fast Track designation; PreHevbrio hepatitis B vaccine now available; And the FDA update a safety communication regard the risk of thyroid dysfunction in infants following the use of contrast…
All unvaccinated adults at risk for infection should be vaccinated; screening recommended for at-risk
The approval was based on data from two phase 3 studies, which compared the safety and immunogenicity of PreHevbrio to Engerix-B in adults.
IDWeek 2015: Vaccines
Neonatal acellular pertussis vaccination may be a safe alternative to maternal immunization, according to efficacy data presented at IDWeek 2015.
For the analysis, study authors looked at data specifically for patients with type 2 diabetes aged 60 to 70 years.